Hemp & CBD Summit

November 6th, 2019
7.30 – 8.30 Registration and Networking Breakfast
8:30 – 8.40 Opening Remarks by the Summit Chair

National Regulatory Overview
8:40 – 9:00 Presentation:
The 2018 Farm Bill and Its Implications on Industrial Hemp and CBD
A high-level overview of the 2018 Farm Bill and what it means for hemp and CBD industry
stakeholders, regulators, and law enforcement.
9:00 – 9:45 Presentation:
USDA: Understanding Federal Hemp Laws and Regulations
This presentation focuses on the U.S. Department of Agriculture and their position on industrial
hemp, current regulation, strategies and best practices on how to maintain compliance in this
rapidly evolving industry.
Bill Richmond, Hemp Program Manager, USDA
9:45 – 10:15 Networking Break

10:15 – 11:00 Presentation:
FDA: The Food, Drug, and Cosmetics Act and How it Applies to CBD
A crucial part of thriving in this industry is maintaining compliance with rapidly evolving
regulations. This presentation focuses on the FDA’s current position on CBD and hemp-derived
products.
Coleen Klasmeier, Partner, SIDLEY AUSTIN and Former Staff Attorney and Special Assistant to
the Chief Counsel, FDA

11:00 – 11:30 Solution Provider Presentation:
Challenges and Opportunities in Hemp Regulation
Alex Spelman, Vice President, SICPA
11:30 – 12:30 Panel Discussion:
Pharmaceuticals: How FDA Approval of Epidiolex has affected the Industry
The ripples of FDA approval of Epidiolex are still reverberating throughout the industry.
Misinformation abounds amongst operators on issues like the prior marketing rule and product
labeling. This panel will discuss what Epidiolex means for your business and the CBD industry at large.
Panelists:
Daniel Fabricant, Chief Executive, NATURAL PRODUCTS ASSOCIATION
David Mangone, Esq., Director of Government Affairs, AMERICANS FOR SAFE ACCESS

12:30 – 2:00 Group Networking Luncheon
State Perspectives on Regulation
2:00 – 3:00 Panel Discussion:
Lessons Learned From State Hemp Programs Across the U.S.
A patchwork of state industrial hemp programs across the U.S. has allowed for a variety of
approaches to regulation. This panel brings together multiple state departments of agriculture
to discuss policies that work and how to improve on ineffective policies.
Panelists:
Axel Bernabe, Assistant Counsel to the Governor for Health, NEW YORK STATE
Brian Koontz, Industrial Hemp Program Manager, COLORADO DEPARTMENT OF AGRICULTURE
Taryn LaScola-Miner, Director, Crop and Pest Services, MASSACHUSETTS DEPARTMENT OF
AGRICULTURAL RESOURCES
Wendy Mosher, President & CEO, NEW WEST GENETICS, INC.
John Ryan, COO, ANANDA HEMP

3:00 – 4:00 Panel Discussion:
How CBD is regulated by State Public Health Departments
Even with prohibitive regulations, CBD and other hemp derived products are proliferating
everywhere from gas stations to grocery stores across the country. Hear from state public
health departments about their approaches to CBD and consumer safety.
Panelists:
Blake Butler, Executive Director, NORTH CAROLINA INDUSTRIAL HEMP ASSOCIATION
Nick French, Founder, COLORADO HEMP HONEY
Jeff Lawrence, Division Director, COLORADO DEPARTMENT OF PUBLIC HEALTH AND
ENVIRONMENT
André Ourso, JD, MPH, Administrator, Center for Health Protection, Public Health Division,
OREGON HEALTH AUTHORITY

4:00 – 5:00 Panel Discussion:
Interstate Commerce Considerations in Hemp and CBD
The interstate transportation of hemp is lawful for hemp grown under a USDA approved
program, pursuant to the 2018 Farm Bill, but a patchwork of regulations across the U.S. has
created confusion amongst industry stakeholders, regulators, and law enforcement alike. This
panel will focus on cautionary tales and lessons learned from constantly evolving regulations.
Panelists:
Michael Joseph French, President, AGTECH SCIENTIFIC
Lt. Colonel Sheldon Kelley, Deputy Director, IDAHO STATE POLICE
Geoff Whaling, Chair, NATIONAL HEMP ASSOCIATION
5:00 Summit Day 1 Adjourns

November 7th, 2019

7.30 – 8.30 Registration and Networking Breakfast
8:30 – 8.40 Opening Remarks by the Summit Chair

The Growing Hemp and CBD Industry
8:40 – 9:00 Presentation:
Hemp and CBD Market Overview
A high-level overview of market dynamics, trends, and opportunities.

9:00 – 10:00 Panel Discussion:
International Commerce and Trade Issues with Hemp and CBD
As the U.S. market continues to develop, companies may shift their focus to the international
market, but selling hemp or hemp CBD products internationally is bursting with various legal
and regulatory concerns. This panel will provide a primer on how to maintain compliance and
streamline international operations.
Panelists:
Chris Husong, Vice President, Marketing and Communications, ELIXINOL
Brent Williams, Managing Member, HIGHWATER FINANCIAL, LLC
Additional Panelists to be Announced

10:00 – 10:30 Presentation:
Software Solutions Presentation
10:30 – 11:00 Networking Break
11:00 – 12:00 Panel Discussion:
Corporate Appetite for CBD and Other Hemp Derived Products
With major drug stores and supermarkets announcing they will be carrying CBD products,
stakeholders across the supply chain are vying for distribution agreements on a national scale.
This panel of executives will discuss their perspectives on the CBD market and consumer appetite for hemp-derived products.
Panelists:
Janet Hart, Director of Government Affairs, RITE AID
Remy Isaac, Executive Director, AATAC
Paul Rock, Chairman, ASSOCIATION PARTNERS

12:00 – 1:00 Panel Discussion:
Developing a Compliant and Reliable Supply Chain
With new states coming on line with hemp regulations and farmers scrambling to get plants in
the ground, it’s important to forge partnerships with stakeholders across the supply chain to
develop quality, compliant product. This panel focuses on strategies, best practices and
dynamics within the hemp and CBD supply chain as a whole.
Panelists:
Jaclyn Bowen, MPH, MS, Executive Director, CLEAN LABEL PROJECT
Kurt Forstmann, Vice President of Corporate Development, DIXIE BRANDS
William Hilliard, CEO, ATALO HOLDINGS, INC. (invited)
Duffy MacKay, ND, SVP, Scientific and Regulatory Affairs, CV SCIENCES

1:00 – 2:30 Group Networking Luncheon

Testing Standards, Science, and Education
2:30 – 3:30 Panel Discussion:
The Science of Hemp, CBD, and Other Minor Cannabinoids
With buzz words like the “entourage effect” and “full spectrum” flooding the social
consciousness, it can be hard to distinguish what they mean, how they affect the human body
and in turn marketing efforts. Understanding the basics of the endocannabinoid system is
crucial to formulating and marketing a high-quality product in this ever increasingly saturated
market. This high-level overview of the science around CBD and other cannabinoids will provide
you valuable knowledge on the interactions cannabinoids catalyze.
Panelists:
Roger M. Brauninger, M.S., Biosafety Program Manager, AMERICAN ASSOCIATION FOR
LABORATORY ACCREDITATION (A2LA)
Brian King, CSO, CBD ENERGY, LLC
Brian C. Smith, Ph.D., CEO, Founder, & Chief Technical Officer, BIG SUR SCIENTIFIC

3:30 – 4:30 Panel Discussion:
Educating Consumers about Hemp and CBD: Concentrations and Sourcing Matters
Sourcing of product, dosage concentrations and methods of administration are important
factors to consider for manufacturers, brands and consumers alike. All of these factors are
consequential not only for product efficacy but marketing and branding efforts as well. Take a
deep dive on best practices and lessons learned from these expert industry stakeholders.
Panelists:
Lawrence Hudson, Senior Vice President, Business development & Consumer Brands, DR.
KERKLAAN THERAPEUTICS
Chris Husong, Vice President, Marketing and Communications, ELIXINOL
Michael Krawitz, Executive Director, VETERANS for MEDICAL CANNABIS ACCESS

4:30 Summit Adjourns